BioVaxys Technology Corp.
BIOV
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.54% | -131.77% | -296.27% | -12.90% | 59.08% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -166.13% | 2,828.40% | 88.07% | 26.32% | -40.62% |
| Change in Net Operating Assets | 227.59% | 880.63% | -20.79% | -88.39% | -174.28% |
| Cash from Operations | -155.48% | 98.23% | -34,994.44% | -49,480.00% | -1,591.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 4.53% | -- | -- | -- |
| Cash from Investing | -- | 4.53% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00% | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 29.89% | -12.01% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 25.38% | -16.40% | -- | -- |
| Foreign Exchange rate Adjustments | 100.00% | -- | -785.71% | 31.58% | 96.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.08% | 81.85% | -105.36% | -51,200.00% | 1,251.43% |